accepted and acknowledged
on 31 Jul 2024
Last Applicant/ Owned by
350 Oyster Point Blvd
South San Francisco
CA
94080
Serial Number
86264078 filed on 28th Apr 2014
Registration Number
5380852 registered on 16th Jan 2018
Correspondent Address
B. Brett Heavner
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP
WASHINGTON, DC 20001
United States
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]
Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]
01st Jun 2009
01st Jun 2009
No 86264078
No Service/Collective Mark
No 09367.0198
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
31st Jul 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
31st Jul 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
30th Jul 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
16th Jan 2024 | TEAS SECTION 8 & 15 RECEIVED |
16th Jan 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
16th Jan 2018 | REGISTERED-PRINCIPAL REGISTER |
13th Dec 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
12th Dec 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
30th Nov 2017 | STATEMENT OF USE PROCESSING COMPLETE |
27th Nov 2017 | USE AMENDMENT FILED |